Infliximab and etanercept are equally effective in reducing enterocyte APOPTOSIS in experimental colitis - Wikidata - wikimedia - TriplyDB

Infliximab and etanercept are equally effective in reducing enterocyte APOPTOSIS in experimental colitis

Infliximab and etanercept are equally effective in reducing enterocyte APOPTOSIS in experimental colitis

http://www.wikidata.org/entity/Q36755033

about

Fc gamma receptor CD64 modulates the inhibitory activity of infliximab Balsalazine decreases intestinal mucosal permeability of dextran sulfate sodium-induced colitis in mice.Etanercept protects rat cardiomyocytes against hypertrophy by regulating inflammatory cytokines secretion and cell apoptosis Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease Anti-TNF-alpha therapy does not ameliorate disease in a model of acute virus-endotoxin mediated respiratory disease in pigs.Etanercept biosimilars Ablation of tumor necrosis factor is associated with decreased inflammation and alterations of the microbiota in a mouse model of inflammatory bowel disease.Loss of ADAM17-Mediated Tumor Necrosis Factor Alpha Signaling in Intestinal Cells Attenuates Mucosal Atrophy in a Mouse Model of Parenteral Nutrition Clinically validated approaches to the treatment of autoimmune diseases.Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists.Dendritic cells expressing immunoreceptor CD300f are critical for controlling chronic gut inflammation Molecular pathways driving disease-specific alterations of intestinal epithelial cells.The combination of a tumor necrosis factor inhibitor and antibiotic alleviates staphylococcal arthritis and sepsis in mice.Anti-inflammatory effects of infliximab in mice are independent of tumour necrosis factor α neutralization.How bacteria-induced apoptosis of intestinal epithelial cells contributes to mucosal inflammation.Antibiotic-killed Staphylococcus aureus induces destructive arthritis in mice.Myosin light chain kinase inhibitor inhibits dextran sulfate sodium-induced colitis in mice.The Cytosolic Microbial Receptor Nod2 Regulates Small Intestinal Crypt Damage and Epithelial Regeneration following T Cell-Induced Enteropathy.Intrarectal administration of oxygenated perfluorodecalin promotes healing of murine colitis by targeting inflammatory hypoxia.TNFα depleting therapy improves fertility and animal welfare in TNFα-driven transgenic models of polyarthritis when administered in their routine breeding.Tumour necrosis factor--induced loss of intestinal barrier function requires TNFR1 and TNFR2 signalling in a mouse model of total parenteral nutrition.Etanercept attenuates TNBS-induced experimental colitis: role of TNF-α expression.

P2860

Q28482601-F1835B2A-5EC1-45FB-832C-B1E03852F8D1 Q33552613-F5EADC1A-9684-492E-81FE-1DAD5C2D3495 Q33821362-9A22588C-32DB-406C-84FF-9759CE7729B9 Q33865593-B1E56F98-126C-43A7-B2E6-0BDE3CE0BE4D Q34069240-9F76D24B-C4F6-4904-BBE9-FA442BF6A6E1 Q35020358-8E16C415-A132-4FAB-B0E8-59F28EF4A934 Q35182119-7606F60B-68CB-40D9-AB06-7E5A9C352844 Q36109388-A7461A24-E36E-4FC0-8629-A280D20FBAA0 Q37668612-67288131-EA5C-43E0-A8EB-C4EF999972BE Q38239111-DCF13780-9AE9-4605-A784-18D7850099C3 Q38834628-4C6C1871-01C0-4A4B-9B1A-7F071E22B4D4 Q38953543-BD1BCC64-F165-4D87-9854-86A01D83FC38 Q39262917-C0256F71-0F76-440A-8A52-253A131B7819 Q39350996-8C6067B0-0368-4447-9E4D-18764CC81507 Q41216095-CD8EAFDC-DAC6-46E0-AF3A-9022D62B6016 Q41706624-C3078E33-440F-4219-90ED-9AA82953729E Q43474062-89768741-D057-4366-B8B2-1849E579DC70 Q48227845-6F62CD5B-3923-4786-BBA1-5D7B7C931CB7 Q49055653-0232C8CB-6C4E-439C-8B3D-65B517B0FAA4 Q50233826-C8827E53-C747-483E-AC08-8DAD6F319AF3 Q50920142-7F3ABC5D-898C-4411-A386-5C51BB35B882 Q54352517-953D2A50-276A-4DE8-A493-40F049F9BF2E

P2860

Infliximab and etanercept are equally effective in reducing enterocyte APOPTOSIS in experimental colitis

http://www.wikidata.org/entity/Q36755033

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Infliximab and etanercept are ...... PTOSIS in experimental colitis

@ast

Infliximab and etanercept are ...... PTOSIS in experimental colitis

@en

type

label

Infliximab and etanercept are ...... PTOSIS in experimental colitis

@ast

Infliximab and etanercept are ...... PTOSIS in experimental colitis

@en

prefLabel

Infliximab and etanercept are ...... PTOSIS in experimental colitis

@ast

Infliximab and etanercept are ...... PTOSIS in experimental colitis

@en

P1433

Q36755033-A997208D-5C64-4002-8FD9-D89BEA8FF9CA

P1476

Q36755033-AF0FE82D-F07A-40E0-9C17-55B1D18BE762

P2093

Q36755033-0FD85254-815E-4185-B76F-7C9548594F2D

Q36755033-A9837793-B909-41FA-8E33-CB32B35D8B70

Q36755033-AB1ED543-67A9-489B-B1E7-E85AA525D442

Q36755033-AD27B6E0-4468-41D4-94AB-8B9114ACE78B

Q36755033-B6ADB218-4822-4FCB-96EC-0642F0189C78

P2860

Q36755033-0375DCE5-95D2-410C-A027-12CB45AF96A2

Q36755033-099334FD-0B88-4D30-980B-D70161D7B8E0

Q36755033-0BA80B5B-CC2E-49D8-919F-E4EBC2FA8616

Q36755033-1117A7B2-6677-4E48-B977-5CE034CFF7D0

Q36755033-181BA3D8-010F-4263-8DE4-06CB36E86244

Q36755033-1A5AE1B8-1D25-4685-AB3D-BEB4F0C7A441

Q36755033-2482CD16-0090-44A3-B769-6AD66D7D7F08

Q36755033-3741FDC5-403F-4A93-9DAD-1D4E4B40AFEC

Q36755033-3F05EAE5-2888-4F4C-9058-AAF26734BE69

Q36755033-467A5EEE-2455-4758-9FBD-4D5F49C01982

P304

Q36755033-65D1968F-B174-4EAE-8717-4B9B26C5779F

P31

Q36755033-805F044F-BC0B-4539-90AE-CFF5CF81A35A

P356

Q36755033-1060F6BA-1F29-4AFD-812A-8C8E9B093375

P407

Q36755033-F6C1EAF1-8618-4673-BDF4-506F491C3E8B

P433

Q36755033-770D29F4-5E84-40E5-B65E-FDDC5F648F5F

P478

Q36755033-E3D96646-39F5-4123-8272-1223D8FB43C5

P50

Q36755033-21B02A1C-299C-4944-9F64-A3FE70610869

Q36755033-A9D8A4E6-0D5E-4488-86F1-A8E57DF53CF0

P577

Q36755033-74FD8822-2513-466C-9FE9-8112D71FC2AA

P698

Q36755033-C32F08A5-290F-4BA9-8C4F-DCD29F66F001

P932

Q36755033-C8494410-B6AA-4310-925A-AA8A1FDA00B4

P356

P1433

International Journal of Medical Sciences

P1476

Infliximab and etanercept are ...... PTOSIS in experimental colitis

@en

P2093

Carmela Crisafulli

http://www.w3.org/2001/XMLSchema#string

Carmelo Muja

http://www.w3.org/2001/XMLSchema#string

Giuseppe Costantino

http://www.w3.org/2001/XMLSchema#string

Giuseppe Longo

http://www.w3.org/2001/XMLSchema#string

Walter Fries

http://www.w3.org/2001/XMLSchema#string

P2860

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

Certolizumab pegol for the treatment of Crohn's disease

TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis.

Tumor necrosis factor-alpha induces apoptosis of enterocytes in mice with fulminant hepatic failure.

Alterations in intestinal permeability.

Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease

A porous defense: the leaky epithelial barrier in intestinal disease.

T cell apoptosis and inflammatory bowel disease.

Inflammatory bowel disease and the apical junctional complex.

Disrupted barrier function through epithelial cell apoptosis.

P304

169-180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/IJMS.5.169

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Emanuela Mazzon

Salvatore Cuzzocrea

P577

2008-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18645606

http://www.w3.org/2001/XMLSchema#string

P932

2452978

http://www.w3.org/2001/XMLSchema#string